Task: Answer the multiple-choice question.
Question: Which drug exhibits a -8.025\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CC(C)C1Oc2ccccc2N(CC(=O)N(C)C2CCCCC2)C1=O
[b] CCCOC(=O)c1c(N)n(Cc2cccs2)c2nc3ccccc3nc12
Answer: b. CCCOC(=O)c1c(N)n(Cc2cccs2)c2nc3ccccc3nc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCOC(=O)c1c(N)n(Cc2cccs2)c2nc3ccccc3nc12
CCCOC(=O)c1c(N)n(Cc2cccs2)c2nc3ccccc3nc12
propyl 2-amino-1-(thiophen-2-ylmethyl)pyrrolo[3,2-b]quinoxaline-3-carboxylate